Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 121
interventional 91
Observational 26
Registry 4

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 26
Drug|placebo 17
Procedure 13
Device 11
Device|Drug|Procedure 4
Other 4
Device|Procedure 3
Diagnostic Test 2
Dietary Supplement 2
Drug|Procedure 2
Behavioral|Other 1
Biological|Diagnostic Test|Other 1
Device|Drug 1
Dietary Supplement|placebo 1
Drug|Other 1
Drug|placebo|Procedure 1
Other|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
China 25
United States 16
Spain 8
France 5
India 5
NA 4
Brazil 3
Austria 2
Canada 2
Denmark 2
Egypt 2
Pakistan 2
United Kingdom 2
Belgium 1
Belgium|Netherlands 1
China|Turkey 1
Dominican Republic 1
Ecuador 1
Israel 1
Korea, Republic of 1
Poland 1
Taiwan 1
United States|Australia|France|New Zealand|Spain 1
United States|France|Spain|Switzerland 1
United States|Germany|Spain 1
United States|Spain|United Kingdom 1

Sites per Study

Site_count Study_Count
1 63
2 6
3 4
4 1
5 1
6 5
7 1
8 2
9 1
11 1
12 1
15 1
16 1
19 1
38 1
46 1

Phase

Phase Study_Count
N/A 48
Phase 4 14
Phase 2 12
Phase 3 9
Phase 1/Phase 2 3
Phase 2/Phase 3 3
Phase 1 2

Number of Arms

Number_of_Arms Count_of_Studies
1 20
2 52
3 10
4 3
6 1
7 1
NA 4

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 10.0000 19.0 18.0 10.00000 40 34.0000 20.0000
1st Qu. 47.0000 22.5 28.5 20.50000 41 70.0000 52.5000
Median 100.0000 26.0 39.0 27.00000 42 150.0000 118.0000
Mean 125.2917 26.0 49.0 58.16667 54 148.1111 132.0714
3rd Qu. 141.0000 29.5 64.5 52.25000 61 200.0000 190.0000
Max. 512.0000 33.0 90.0 240.00000 80 360.0000 320.0000

Trial Group Type

group_type Group_Count
Experimental 80
Active Comparator 51
Placebo Comparator 29
No Intervention 12
Other 6
NA 4
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Parallel Assignment 64
Single Group Assignment 24
NA 2
Crossover Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 50
Prevention 19
Diagnostic 13
Health Services Research 3
Basic Science 2
Device Feasibility 1
Other 1
Screening 1
Supportive Care 1

Observational Studies

Studies by Country

Country Study_Count
Denmark 4
United States 4
China 3
Germany 3
NA 3
Australia 1
Austria 1
Brazil|China|Indonesia|Italy|Japan|Korea, Republic of|Turkey 1
Canada 1
Croatia 1
Ecuador 1
Spain 1
Turkey 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 21
2 3
6 1
10 1

Enrollment Metrics

Measure Observational
Min 16.00
1st Qu 54.00
Median 75.00
Mean 184.16
3rd Qu 200.00
Max 1000.00

Observation Model

observational_model Study_Count
Cohort 17
Case-Control 3
Case-Only 3
Case Control 1
Defined Population, Natural History 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 21
Cross-Sectional 1
Cross-Sectional, Retrospective 1
Other 1
Retrospective 1
NA 1

Registries

Studies by Country

Country Study_Count
Austria 3
China 1

Sites per Study

Site_count Study_Count
1 4

Enrollment Metrics

Measure Registries
Min 150.0
1st Qu 337.5
Median 508.0
Mean 2791.5
3rd Qu 2962.0
Max 10000.0

Registry Model

observational_model Study_Count
Cohort 3
Case-Only 1

Time Perspective

time_perspective Study_Count
Prospective 3
Cross-Sectional 1

Follow-up

target_duration Study_Count
1 Year 1
10 Years 1
2 Years 1
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03825848 The Influence of Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy https://ClinicalTrials.gov/show/NCT03825848 Recruiting Shanghai Zhongshan Hospital 2023-12-31
NCT03171805 The Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric Varices https://ClinicalTrials.gov/show/NCT03171805 Recruiting West China Hospital 2020-05-15
NCT03171727 Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction https://ClinicalTrials.gov/show/NCT03171727 Recruiting West China Hospital 2019-05-15
NCT03138915 Radiomics Signature of Hepatic Venous Pressure Gradient (rHVPG) With CT Angiography (CHESS1701) https://ClinicalTrials.gov/show/NCT03138915 Completed Nanfang Hospital of Southern Medical University 2017-10-08
NCT03094234 8mm-TIPS Versus Endoscopic Variceal Ligation (EVL) Plus Propranolol for Prevention of Variceal Rebleeding in Patients With Child A Cirrhosis https://ClinicalTrials.gov/show/NCT03094234 Recruiting West China Hospital 2019-03-28
NCT03031366 A Novel Approach for Transjugular Intrahepatic Portocaval Shunt Creation Using Real-time Three Dimensional Roadmap https://ClinicalTrials.gov/show/NCT03031366 Completed West China Hospital 2017-05-30
NCT02994485 Evaluation Of The Portal Pressure By Doppler Ultrasound In Cirrhotic Patients Before And After Simvastatin https://ClinicalTrials.gov/show/NCT02994485 Completed Tanta University 2018-02-28
NCT02960204 Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension https://ClinicalTrials.gov/show/NCT02960204 Completed Conatus Pharmaceuticals Inc. 2018-10-02
NCT02945982 Treatment of Moderate and Severe Cirrhotic Portal Hypertension Due to HBV With Fuzheng Huayu and Entecavir https://ClinicalTrials.gov/show/NCT02945982 Recruiting ShuGuang Hospital 2020-06-30
NCT02945956 Treatment of Low-grade Cirrhotic Portal Hypertension Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir https://ClinicalTrials.gov/show/NCT02945956 Recruiting ShuGuang Hospital 2020-06-30
NCT02925975 Early Precise Diagnosis and Intervention of CPT Based on a Noninvasive 3D-vHPS https://ClinicalTrials.gov/show/NCT02925975 Active, not recruiting Shanghai Tongji Hospital, Tongji University School of Medicine 2020-06-30
NCT02907749 Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis https://ClinicalTrials.gov/show/NCT02907749 Active, not recruiting Shanghai Tongji Hospital, Tongji University School of Medicine 2020-06-01
NCT02859610 Microparticles in Cirrhosis and Portal Hypertension https://ClinicalTrials.gov/show/NCT02859610 Completed Centre Hospitalier Universitaire de Besancon 2015-01-31
NCT02850692 Portal Hypertension and Systemic Endothelial Function https://ClinicalTrials.gov/show/NCT02850692 Recruiting Hopital Foch 2021-12-31
NCT02842697 Virtual Hepatic Venous Pressure Gradient (vHVPG) With CT Angiography (CHESS1601) https://ClinicalTrials.gov/show/NCT02842697 Completed Nanfang Hospital of Southern Medical University 2017-04-30
NCT02802228 Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients https://ClinicalTrials.gov/show/NCT02802228 Completed Cumberland Pharmaceuticals 2018-07-17
NCT02778425 The Treatment of Hepatocirrhosis and Portal Hypertension https://ClinicalTrials.gov/show/NCT02778425 Recruiting Qilu Hospital of Shandong University 2019-02-28
NCT02776553 A Physical Activity Program in End-state Liver Disease https://ClinicalTrials.gov/show/NCT02776553 Active, not recruiting University of Arkansas 2020-05-31
NCT02669875 Serelaxin To Lower Portal Pressure https://ClinicalTrials.gov/show/NCT02669875 Completed University of Edinburgh 2018-08-31
NCT02508298 Surrogate Markers of Portal Pressure https://ClinicalTrials.gov/show/NCT02508298 Completed VA Connecticut Healthcare System 2018-07-31
NCT02504034 Interventional Radiology for the Treatment of Symptomatic Portal Hypertension in Patients With Cavernous Transformation of Portal Vein https://ClinicalTrials.gov/show/NCT02504034 Recruiting Sun Yat-sen University 2020-12-31
NCT02489045 Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension https://ClinicalTrials.gov/show/NCT02489045 Completed Thomas Jefferson University 2019-03-31
NCT02477384 8mm-TIPS Versus Endoscopic Variceal Ligation (EVL) Plus Propranolol for Prevention of Variceal Rebleeding https://ClinicalTrials.gov/show/NCT02477384 Recruiting West China Hospital 2019-06-30
NCT02465645 To Compare the Efficacy and Safety of Carvedilol With or Without Simvastatin in Patients With Portal Hypertension and Esophageal Varices. https://ClinicalTrials.gov/show/NCT02465645 Completed Institute of Liver and Biliary Sciences, India 2017-01-31
NCT02462967 Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis https://ClinicalTrials.gov/show/NCT02462967 Completed Galectin Therapeutics Inc. 2017-10-31
NCT02439567 Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C) https://ClinicalTrials.gov/show/NCT02439567 Completed Hospital Universitari Vall d’Hebron Research Institute 2016-07-31
NCT02344719 Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02344719 Completed Medical University of Vienna 2015-05-31
NCT02230683 A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension https://ClinicalTrials.gov/show/NCT02230683 Completed Conatus Pharmaceuticals Inc. 2015-05-31
NCT02143778 Assessing Portal Hypertension With Methacetin Breath Test https://ClinicalTrials.gov/show/NCT02143778 Completed Exalenz Bioscience LTD. 2018-12-31
NCT02134626 Simvastatin Effect on Portal Hypertension https://ClinicalTrials.gov/show/NCT02134626 Completed Universidade Federal do Rio de Janeiro 2014-04-30
NCT01290172 Evaluation of Efficacy and Safety of Somatostatin Used as Inflow Modulator in Liver Transplantation. https://ClinicalTrials.gov/show/NCT01290172 Completed University Hospital, Ghent 2013-12-31
NCT02053571 Evaluation of 3D Overlay During Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedure https://ClinicalTrials.gov/show/NCT02053571 Completed Medical College of Wisconsin 2016-08-04
NCT02046473 3D Sonographic Measurement of Volumetric Flow in Transjugular Intrahepatic Porto-Systemic Shunts https://ClinicalTrials.gov/show/NCT02046473 Completed University of Michigan 2015-01-31
NCT01931826 Treatment Schistosomal Portal Hypertension: Efficacy of Endoscopy or Surgery https://ClinicalTrials.gov/show/NCT01931826 Completed Universidade Estadual de Ciências da Saúde de Alagoas 2005-03-31
NCT01923064 Injection of Cyanoacrylate+Lipiodol vs Cyanoacrylate+Lauromacrogol in Gastric Varices https://ClinicalTrials.gov/show/NCT01923064 Completed Shanghai Zhongshan Hospital 2013-12-31
NCT01851252 MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy https://ClinicalTrials.gov/show/NCT01851252 Completed Exalenz Bioscience LTD. 2017-08-31
NCT01816256 Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT01816256 Completed University Health Network, Toronto 2019-03-11
NCT01714609 Pilot Study of Effect of Sorafenib on Portal Pressure https://ClinicalTrials.gov/show/NCT01714609 Completed Yale University 2013-09-30
NCT01687257 Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation https://ClinicalTrials.gov/show/NCT01687257 Completed Gilead Sciences 2015-01-31
NCT01644656 Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI) https://ClinicalTrials.gov/show/NCT01644656 Completed VA Connecticut Healthcare System 2018-09-30
NCT01642446 Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension https://ClinicalTrials.gov/show/NCT01642446 Recruiting Sun Yat-sen University 2022-06-30
NCT01640964 An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension https://ClinicalTrials.gov/show/NCT01640964 Completed Novartis 2014-12-31
NCT01598064 Probiotics for Liver Cirrhosis With Portal Hypertension https://ClinicalTrials.gov/show/NCT01598064 Completed National Cheng-Kung University Hospital 2013-08-31
NCT01551966 Esophageal Capsule Endoscopy in Children https://ClinicalTrials.gov/show/NCT01551966 Completed Hospices Civils de Lyon 2013-07-31
NCT01456286 Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension https://ClinicalTrials.gov/show/NCT01456286 Completed Fundacion Clinic per a la Recerca Biomédica 2013-10-31
NCT01440829 The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS https://ClinicalTrials.gov/show/NCT01440829 Completed Fourth Military Medical University 2012-12-31
NCT01410591 TIPS With 8- OR 10-mm Covered Stent for Preventing Variceal Rebleeding https://ClinicalTrials.gov/show/NCT01410591 Completed Fourth Military Medical University 2016-01-31
NCT01408966 Effects of Dark vs. White Chocolate on the Postprandial Increase in Portal Pressure in Cirrhosis https://ClinicalTrials.gov/show/NCT01408966 Completed Hospital Clinic of Barcelona 2008-10-31
NCT04397289 Anticoagulation Therapy After Splenectomy in Cirrhosis Patient https://ClinicalTrials.gov/show/NCT04397289 Recruiting First Affiliated Hospital Xi’an Jiaotong University 2021-03-31
NCT04315571 Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion Stents https://ClinicalTrials.gov/show/NCT04315571 Recruiting University of California, Los Angeles 2023-01-01
NCT04195971 Dual Arterial Phase Liver CT in Patients With Suspected Portal Hypertension https://ClinicalTrials.gov/show/NCT04195971 Recruiting Seoul National University Hospital 2020-12-31
NCT04191369 EGD vs EUS in Diagnosing Portal Hypertension in Cirrhotic Patients. https://ClinicalTrials.gov/show/NCT04191369 Recruiting Instituto Ecuatoriano de Enfermedades Digestivas 2020-11-01
NCT04111133 Ivabradine in Cirrhotic Cardiomyopathy https://ClinicalTrials.gov/show/NCT04111133 Recruiting Postgraduate Institute of Medical Education and Research 2021-10-31
NCT04073290 Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose https://ClinicalTrials.gov/show/NCT04073290 Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2022-09-30
NCT03175731 PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors) https://ClinicalTrials.gov/show/NCT03175731 Completed Qilu Hospital of Shandong University 2019-08-30
NCT03932552 Effects of a Novel Physical Exercise Program in Patients With Cirrhosis (the LFN-exercise Protocol) https://ClinicalTrials.gov/show/NCT03932552 Active, not recruiting Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2018-12-31
NCT03827200 A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03827200 Recruiting Noorik Biopharmaceuticals AG 2020-09-30
NCT03783065 HVPG-guided Laparoscopic Versus Endoscopic Therapy for Variceal Rebleeding in Portal Hypertension: A Multicenter Randomized Controlled Trial (CHESS1803) https://ClinicalTrials.gov/show/NCT03783065 Recruiting Nanfang Hospital of Southern Medical University 2019-10-28
NCT03766880 MR-based Models for Clinically Significant Portal Hypertension in Cirrhosis (CHESS1802) https://ClinicalTrials.gov/show/NCT03766880 Completed Nanfang Hospital of Southern Medical University 2019-04-30
NCT03748563 DS-MCE vs EGD for Diagnosing Gastroesophageal Varices https://ClinicalTrials.gov/show/NCT03748563 Recruiting Changhai Hospital 2019-12-31
NCT03736265 Carvedilol for Prevention of Esophageal Varices Progression https://ClinicalTrials.gov/show/NCT03736265 Recruiting Beijing Friendship Hospital 2020-12-30
NCT03720067 Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension https://ClinicalTrials.gov/show/NCT03720067 Recruiting Universidade Federal do Rio de Janeiro 2020-12-20
NCT03532750 Splenic Embolization for Portal Hypertension https://ClinicalTrials.gov/show/NCT03532750 Recruiting University of Minnesota 2021-07-01
NCT03470389 Establishment and Assessment of the HVPG Using Biofluid Mechanics (HVPGBFM) https://ClinicalTrials.gov/show/NCT03470389 Recruiting Shanghai Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University 2020-09-30
NCT03451149 Feasibility And Safety Of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Using A Radiofrequency Guidewire https://ClinicalTrials.gov/show/NCT03451149 Completed Oregon Health and Science University 2019-01-29
NCT03427164 Ultrasound Elastography Assessment of Spleen and Liver Stiffness Before and After Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedure https://ClinicalTrials.gov/show/NCT03427164 Recruiting University of Kansas Medical Center 2020-12-31
NCT01267669 A Trial of Somatostatin With Endoscopic Variceal Ligation (EVL) in Control of Acute Variceal Bleeding https://ClinicalTrials.gov/show/NCT01267669 Completed Govind Ballabh Pant Hospital 2009-11-30
NCT01131962 Comparing Two Methods to Stop Vomiting of Blood Using the Endoscope https://ClinicalTrials.gov/show/NCT01131962 Completed University of Alexandria 2011-09-30
NCT01095185 Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding https://ClinicalTrials.gov/show/NCT01095185 Completed Hospital Clinic of Barcelona 2013-09-30
NCT01072721 Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic Fibrosis https://ClinicalTrials.gov/show/NCT01072721 Completed Assistance Publique - Hôpitaux de Paris 2017-07-11
NCT01059396 Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal https://ClinicalTrials.gov/show/NCT01059396 Completed Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2015-07-15
NCT01032941 The Effect of Probiotics (VSL) on Portal Hypertension https://ClinicalTrials.gov/show/NCT01032941 Completed University of Alberta 2011-06-30
NCT01000779 Comparison of Endoscopic Variceal Ligation (EVL) With Propranolol in Non Cirrhotic Portal Hypertension (NCPH) https://ClinicalTrials.gov/show/NCT01000779 Completed Govind Ballabh Pant Hospital 2009-10-31
NCT00992888 Inflammation, Immune Activation and Portal Hypertension in Alcoholic Hepatitis https://ClinicalTrials.gov/show/NCT00992888 Completed University of Aarhus 2011-09-30
NCT00831337 Evaluation of Probiotics in the Treatment of Portal Hypertension https://ClinicalTrials.gov/show/NCT00831337 Completed Pomeranian Medical University Szczecin 2010-11-30
NCT01188733 Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT01188733 Completed Mayo Clinic 2000-07-31
NCT04007289 Apixaban for Intrahepatic Non Cirrhotic Portal Hypertension https://ClinicalTrials.gov/show/NCT04007289 Recruiting Assistance Publique - Hôpitaux de Paris 2024-02-15
NCT02178319 Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT02178319 Recruiting Second Affiliated Hospital of Xi’an Jiaotong University 2021-06-30
NCT00766805 Endoscopic Variceal Ligation (EVL)+ Drugs Versus Endoscopic Variceal Ligation (EVL) Alone For Secondary Prophylaxis https://ClinicalTrials.gov/show/NCT00766805 Completed Govind Ballabh Pant Hospital 2006-12-31
NCT00594191 Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension https://ClinicalTrials.gov/show/NCT00594191 Completed Hospital Clinic of Barcelona 2007-04-30
NCT00593528 PTFE Covered Stents Versus Naked Stents in the TIPS (Transjugular Intra-hepatic Porto-systemic Shunt) https://ClinicalTrials.gov/show/NCT00593528 Completed University Hospital, Tours 2011-07-31
NCT00591968 Telesonography Adaptation and Use to Improve the Standard of Patient Care Within a Dominican Community https://ClinicalTrials.gov/show/NCT00591968 Completed Edward Via Virginia College of Osteopathic Medicine 2008-03-31
NCT00570622 Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis https://ClinicalTrials.gov/show/NCT00570622 Completed Medical University of Vienna 2008-11-30
NCT00534677 The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed https://ClinicalTrials.gov/show/NCT00534677 Completed Aga Khan University NA
NCT00493480 Danish Carvedilol Study in Portal Hypertension https://ClinicalTrials.gov/show/NCT00493480 Completed Hvidovre University Hospital 2009-08-31
NCT00450164 Secondary Prophylaxis After Variceal Bleeding in Non-Responders https://ClinicalTrials.gov/show/NCT00450164 Completed Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau NA
NCT00369694 Short Course Terlipressin for Control of Acute Variceal Bleeding https://ClinicalTrials.gov/show/NCT00369694 Completed Aga Khan University 2008-07-31
NCT00331188 Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding https://ClinicalTrials.gov/show/NCT00331188 Completed Debiovision 2008-06-30
NCT00252642 Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C https://ClinicalTrials.gov/show/NCT00252642 Completed Virginia Commonwealth University 2007-09-30
NCT00006398 Prevention of Esophageal Varices by Beta-Adrenergic Blockers https://ClinicalTrials.gov/show/NCT00006398 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2002-09-30
NCT00004796 Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT00004796 Completed Office of Rare Diseases (ORD) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03277651 Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension https://ClinicalTrials.gov/show/NCT03277651 Recruiting Shanghai Zhongshan Hospital 2019-12-31
NCT03114813 Can MRI Evaluate Beta-blocker Response in Portal Hypertension? https://ClinicalTrials.gov/show/NCT03114813 Recruiting University of Nottingham 2019-07-31
NCT03083925 Viatorr CX Case-control Study for Complications of Portal Hypertension https://ClinicalTrials.gov/show/NCT03083925 Completed University Hospital, Bonn 2018-12-01
NCT03072615 Role of SWE-change After TIPS in the Prediction of Prognosis After TIPS https://ClinicalTrials.gov/show/NCT03072615 Completed University Hospital, Bonn 2015-11-30
NCT02653846 Correlation of Liver and Spleen Stiffness by RT-2D-SWE and Severity of Portal Hypertension by HVPG https://ClinicalTrials.gov/show/NCT02653846 Recruiting University Hospital Dubrava 2017-06-30
NCT02635815 Risk Factors for Variceal Bleeding in Egyptian Patients With Non-Cirrhotic Portal Hypertension https://ClinicalTrials.gov/show/NCT02635815 Completed Ain Shams University 2015-06-30
NCT02526641 Macrophages, Portal Hypertension, and Liver Function During AbbVie Treatment of Chronic Hepatitis C https://ClinicalTrials.gov/show/NCT02526641 Active, not recruiting University of Aarhus 2019-03-31
NCT02505113 Cavernous Transformation of Portal Vein： Etiology, Diagnosis, Management and Prognosis https://ClinicalTrials.gov/show/NCT02505113 Recruiting Sun Yat-sen University 2020-12-31
NCT02417740 Natural History of Noncirrhotic Portal Hypertension https://ClinicalTrials.gov/show/NCT02417740 Recruiting National Institutes of Health Clinical Center (CC) 2029-09-04
NCT01751191 HVPG for Rebleeding Risk Stratification https://ClinicalTrials.gov/show/NCT01751191 Completed Hospital Clinic of Barcelona 2012-11-30
NCT04267406 ADAMTS-13 and Von Willebrand Factor Levels and Activities in Children With Cirrhosis and/or Portal Hypertension https://ClinicalTrials.gov/show/NCT04267406 Completed Ataturk University 2019-10-30
NCT04044248 TIPS Plus Transvenous Obliteration for Gastric Varices https://ClinicalTrials.gov/show/NCT04044248 Recruiting University of Illinois at Chicago 2021-04-04
NCT03713606 Serum Biomarkers for Portal Hypertension in Cirrhosis (Pan-CHESS1802) https://ClinicalTrials.gov/show/NCT03713606 Recruiting Nanfang Hospital of Southern Medical University 2019-01-31
NCT03656263 The Clinical Significance of Portal Hypertension After Cardiac Surgery: a Multicenter Prospective Observational Study https://ClinicalTrials.gov/show/NCT03656263 Recruiting Montreal Heart Institute 2021-07-31
NCT03628807 Non-invasive Evaluation Program for TIPS and Follow Up Network https://ClinicalTrials.gov/show/NCT03628807 Completed University Hospital, Bonn 2020-05-11
NCT03483272 MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI) https://ClinicalTrials.gov/show/NCT03483272 Recruiting Hvidovre University Hospital 2023-01-31
NCT03459378 Outcome After TIPS https://ClinicalTrials.gov/show/NCT03459378 Completed Medical University of Graz 2019-03-01
NCT03443934 Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive Assessment https://ClinicalTrials.gov/show/NCT03443934 Recruiting Hvidovre University Hospital 2023-04-30
NCT03438916 MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT03438916 Recruiting Hvidovre University Hospital 2023-04-30
NCT03436550 Assessment of Portal Hypertension With Multiparametric MRI https://ClinicalTrials.gov/show/NCT03436550 Recruiting Icahn School of Medicine at Mount Sinai 2021-11-30
NCT04121520 Perioperative Care of HVPG Measurement (CHESS1904): An International Multicenter Survey https://ClinicalTrials.gov/show/NCT04121520 Recruiting Hepatopancreatobiliary Surgery Institute of Gansu Province 2020-10-31
NCT03155282 Utility of EUS-elastography to Predict Portal Hypertension https://ClinicalTrials.gov/show/NCT03155282 Completed Instituto Ecuatoriano de Enfermedades Digestivas 2017-09-27
NCT04393519 Non-invasive Evaluation Program for TIPS and Follow Up Network 2 (NEPTUN2) https://ClinicalTrials.gov/show/NCT04393519 Recruiting University Hospital, Bonn 2030-12-31
NCT00587197 A Prospective Evaluation of Computerized Tomographic(CT) Scanning as a Screening Modality for Esophageal Varices https://ClinicalTrials.gov/show/NCT00587197 Completed Mayo Clinic 2005-10-31
NCT00519610 Assessing Outcome After H-graft Shunt Placement https://ClinicalTrials.gov/show/NCT00519610 Completed University of South Florida NA
NCT00163631 Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis https://ClinicalTrials.gov/show/NCT00163631 Completed Bayside Health NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03409263 Austrian Registry on Transjugular Intrahepatic Portosystemic Shunts https://ClinicalTrials.gov/show/NCT03409263 Recruiting Medical University of Vienna 2027-12-31
NCT03267615 VICIS - Vienna Cirrhosis Study https://ClinicalTrials.gov/show/NCT03267615 Recruiting Medical University of Vienna 2026-12-31
NCT04123509 Non-invasive Method for Predicting the Presence of Gastroesophageal Varices in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT04123509 Recruiting Nanfang Hospital of Southern Medical University 2020-12-31
NCT03541057 Vienna Vascular Liver Disease Study https://ClinicalTrials.gov/show/NCT03541057 Recruiting Medical University of Vienna 2022-12-31